Lopes VV - Search Results

1

Two decade trends in cardiovascular disease outcomes and cardiovascular risk factors among US veterans living with HIV.

Haji M, Lopes VV, Ge A, Halladay C, Soares C, Shah NR, Longenecker CT, Lally M, Bloomfield GS, Shireman TI, Ross D, Sullivan JL, Rudolph JL, Wu WC, Erqou S. Haji M, et al. Among authors: lopes vv. Int J Cardiol Cardiovasc Risk Prev. 2022 Sep 29;15:200151. doi: 10.1016/j.ijcrp.2022.200151. eCollection 2022 Dec. Int J Cardiol Cardiovasc Risk Prev. 2022. PMID: 36573195 Free PMC article.

2

Variations in antihypertensive medication treatment and blood pressure control among Veterans with HIV and existing hypertension.

Kim CW, Haji M, Lopes VV, Halladay C, Sullivan JL, Ross D, Slazinski K, Taveira TH, Menon A, Gaitanis M, Longenecker CT, Bloomfield GS, Rudolph JL, Wu WC, Erqou S. Kim CW, et al. Among authors: lopes vv. Am Heart J. 2024 Dec;278:48-60. doi: 10.1016/j.ahj.2024.08.009. Epub 2024 Aug 29. Am Heart J. 2024. PMID: 39216692

3

Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System.

Appaneal HJ, LaPlante KL, Lopes VV, Martin C, Puzniak L, Wiemken TL, Zasowski EJ, McLaughlin JM, Caffrey AR. Appaneal HJ, et al. Among authors: lopes vv. Infect Dis Ther. 2024 Jan;13(1):155-172. doi: 10.1007/s40121-023-00910-1. Epub 2024 Jan 13. Infect Dis Ther. 2024. PMID: 38217842 Free PMC article.

4

Real-world utilization of ceftazidime/avibactam among inpatients in the national Veterans Affairs Healthcare System.

Caffrey AR, Appaneal HJ, Lopes VV, Riccobene TA, LaPlante KL. Caffrey AR, et al. Among authors: lopes vv. Am J Health Syst Pharm. 2024 Jun 11;81(12):509-520. doi: 10.1093/ajhp/zxae038. Am J Health Syst Pharm. 2024. PMID: 38365226

5

Exploring variations in recommended first-choice therapy for complicated urinary tract infections in males: Insights from outpatient settings across age, race, and ethnicity.

Sine K, Lavoie T, Caffrey AR, Lopes VV, Dosa D, LaPlante KL, Appaneal HJ. Sine K, et al. Among authors: lopes vv. Pharmacotherapy. 2024 Apr;44(4):308-318. doi: 10.1002/phar.2912. Epub 2024 Mar 14. Pharmacotherapy. 2024. PMID: 38483080

6

Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System.

Caffrey AR, Appaneal HJ, Lopes VV, Puzniak L, Zasowski EJ, Jodar L, LaPlante KL, McLaughlin JM. Caffrey AR, et al. Among authors: lopes vv. Nat Commun. 2024 Nov 2;15(1):9490. doi: 10.1038/s41467-024-53842-w. Nat Commun. 2024. PMID: 39488521 Free PMC article.

7

First report of putative Leishmania RNA virus 2 (LRV2) in Leishmania infantum strains from canine and human visceral leishmaniasis cases in the southeast of Brazil.

Rêgo FD, da Silva ES, Lopes VV, Teixeira-Neto RG, Belo VS, Fonseca Júnior AA, Pereira DA, Pena HP, Laurenti MD, Araújo GV, da Matta VLR, Chouman IH, Burrin TB, Sandoval CM, Barrouin-Melo SM, de Pinho FA, de Andrade HM, Nunes RV, Gontijo CMF, Soccol VT, Klocek D, Grybchuk D, Macedo DH, do Monte-Neto RL, Yurchenko V, Soares RP. Rêgo FD, et al. Among authors: lopes vv. Mem Inst Oswaldo Cruz. 2023 Sep 18;118:e230071. doi: 10.1590/0074-02760230071. eCollection 2023. Mem Inst Oswaldo Cruz. 2023. PMID: 37729273 Free PMC article.

8

Development of quantitative PCR and digital PCR for the quantification of Leishmania infantum in dogs.

Pereira DCA, Teixeira-Neto RG, Lopes VV, Pena HP, Paz GF, Custodio CHX, Belo VS, da Fonseca Júnior AA, da Silva ES. Pereira DCA, et al. Among authors: lopes vv. Mol Cell Biochem. 2023 Nov;478(11):2445-2450. doi: 10.1007/s11010-023-04672-9. Epub 2023 Feb 15. Mol Cell Biochem. 2023. PMID: 36790551

9

Treatment, clinical outcomes, and predictors of mortality among a national cohort of hospitalized patients with Stenotrophomonas maltophilia infection.

Appaneal HJ, Lopes VV, LaPlante KL, Caffrey AR. Appaneal HJ, et al. Among authors: lopes vv. Public Health. 2023 Jan;214:73-80. doi: 10.1016/j.puhe.2022.10.025. Epub 2022 Dec 13. Public Health. 2023. PMID: 36521275

10

Trends in Stenotrophomonas maltophilia antibiotic resistance rates in the United States Veterans Affairs Health System.

Appaneal HJ, Lopes VV, LaPlante KL, Caffrey AR. Appaneal HJ, et al. Among authors: lopes vv. J Med Microbiol. 2022 Oct;71(10). doi: 10.1099/jmm.0.001594. J Med Microbiol. 2022. PMID: 36306237

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters